Tag Archives: SCL

Top 5 Low Price Stocks To Invest In Right Now

Following past boom/bust cycles, the oil business appears to have bottomed in February 2016 at $27 a barrel. The bruising multi-year bust in crude oil prices was the biggest reason for the world stock market sell-off from late 2015 to early 2016 of roughly 15% overall. The cruel irony of ultra-low prices is its disruptive effect on regular exploration activity. A short-term oil market depression in expectations disproportionately slashes oil drilling activity. Oil exploration budgets for 2017 are down 65% from 2014 and the smallest in 12 years, DESPITE a record estimate for global demand next year. In the long-run, oil & gas development and production may fail to keep pace with the steady growth in total demand. Will the 2015-16 “bust” sow the seeds of the next “boom” phase in pricing?

Click to enlarge

Top 5 Low Price Stocks To Invest In Right Now: Stepan Company(SCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.

    Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.

  • [By Stephan Byrd]

    Several research analysts have weighed in on SCL shares. Zacks Investment Research raised Stepan from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research report on Tuesday, January 1st. ValuEngine raised Stepan from a “hold” rating to a “buy” rating in a research report on Monday, February 4th. Stifel Nicolaus started coverage on Stepan in a research report on Monday, December 10th. They issued a “buy” rating and a $94.00 price objective on the stock. Finally, Seaport Global Securities reissued a “hold” rating and issued a $95.00 price objective on shares of Stepan in a research report on Monday, November 5th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $74.50.

    TRADEMARK VIOLATION NOTICE: “Eagle Asset Management Inc. Sells 3,038 Shares of Stepan (SCL)” was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at www.tickerreport.com/banking-finance/4195550/eagle-asset-management-inc-sells-3038-shares-of-stepan-scl.html.

    Stepan Company Profile

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Top 5 Low Price Stocks To Invest In Right Now: VIVUS, Inc.(VVUS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning News Team]

    However, VivoPower and our other penny stocks to watch this week already saw big gains. After looking at our 10 top penny stocks to watch, we’ll show you a small-cap stock with serious profit potential in its future…

    Penny Stock Current Share Price Law Week’s Gain
    VivoPower International Plc. (Nasdaq: VVPR) $3.05 88.57%
    Euro Tech Holdings Co. (Nasdaq: CLWT) $3.77 75.11%
    Boxlight Corp. (Nasdaq: BOXL) $6.36 65.38%
    Chine Recycling Energy Corp. (Nasdaq: CREG) $2.01 45.92%
    Vivis Inc. (Nasdaq: VVUS) $0.52 38.82%
    HC2 Holdings Inc. (NYSE: HCHC) $6.79 33.49%
    Biostar Pharmaceuticals Inc. (Nasdaq: BSPM) $2.67 32.23%
    Turtle Beach Corp. (Nasdaq: HEAR) $6.99 30.19%
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $3.30 29.24%
    Rexahn Pharmaceuticals Inc. (NYSE: RNN) $2.11 29.19%

    While the gains of last week’s top penny stocks are exciting, it’s important to note that investing in penny stocks is also incredibly risky.

  • [By Money Morning Staff Reports]

    But Blink and our other penny stocks to watch are unlikely to continue to lock in such spectacular gains in June. After looking at our 10 top penny stocks to watch this month, we’ll show you a small-cap stock with great profit potential in its future…

    Penny Stock Current Share Price Law Month’s Gain
     Blink Charging Co. (Nasdaq: BLNK) $7.07 439.85%
    Senes Tech Inc. (Nasdaq: SNES) $1.27 175.40%
    Vivis Inc. (Nasdaq: VVUS) $0.77 150.41%
    Adomani Inc. (Nasdaq: ADOM) $1.49 137.68%
    NF Energy Saving Co. (Nasdaq: NFEC) $2.34 134.88%
    Vaalco Energy Inc. (NYSE: EGY) $2.15 109.06%
    Heat Biologics Inc. (Nasdaq: HTBX) $2.35 99.12%
    ArQule Inc. (Nasdaq: ARQL) $4.88 90.74%
    LiqTech International Inc. (NYSE: LIQT) $0.66 85.60%
    Transenterix Inc. (NYSE: TRXC) $3.46 77.84%

    While last month’s gains are tremendous, they also illustrate the inherent dangers that come with investing in penny stocks.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on VIVUS (VVUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Media stories about VIVUS (NASDAQ:VVUS) have been trending somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. VIVUS earned a news impact score of 0.13 on Accern’s scale. Accern also gave press coverage about the biopharmaceutical company an impact score of 47.022479468622 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Low Price Stocks To Invest In Right Now: John Bean Technologies Corporation(JBT)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    John Bean Technologies Corp  (NYSE:JBT)Q4 2018 Earnings Conference CallFeb. 26, 2019, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on John Bean Technologies (JBT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    John Bean Technologies (NYSE:JBT) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $88.00 price target on the stock.

  • [By Max Byerly]

    John Bean Technologies Corp (NYSE:JBT) has been given a consensus recommendation of “Hold” by the ten ratings firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $92.33.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on John Bean Technologies (JBT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In Right Now: Xylem Inc.(XYL)

Advisors’ Opinion:

  • [By Max Byerly]

    Hsbc Holdings PLC cut its holdings in Xylem Inc. (NYSE:XYL) by 7.8% in the first quarter, HoldingsChannel reports. The institutional investor owned 309,799 shares of the industrial products company’s stock after selling 26,335 shares during the quarter. Hsbc Holdings PLC’s holdings in Xylem were worth $23,830,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Xylem Inc (NYSE:XYL) has been assigned an average rating of “Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and nine have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $78.31.

  • [By John Rotonti]

    On the other hand, the right investments in R&D efforts to develop new products and services can help companies differentiate themselves from competitors and build sustainable moats. Xylem (NYSE:XYL), a leading pure-play water technology provider, has increased its R&D investments as a percentage of sales to accelerate the pace of innovation across its product portfolio. 3M (NYSE:MMM), with its diversified product portfolio and strong focus on innovation, is another example.

  • [By Joseph Griffin]

    Xylem Inc (NYSE:XYL) has been assigned an average recommendation of “Buy” from the twelve brokerages that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $79.78.

Top 5 Low Price Stocks To Invest In Right Now: HomeTrust Bancshares, Inc.(HTBI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Hometrust Bancshares (NASDAQ:HTBI) and Dime Community Bancshares (NASDAQ:DCOM) are both small-cap finance companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations.

  • [By Joseph Griffin]

    Hometrust Bancshares (NASDAQ: HTBI) and TFS Financial (NASDAQ:TFSL) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

  • [By Shane Hupp]

    Hometrust Bancshares (NASDAQ:HTBI) was downgraded by equities researchers at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Wednesday.

  • [By Shane Hupp]

    Headlines about Hometrust Bancshares (NASDAQ:HTBI) have trended somewhat positive on Saturday, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Hometrust Bancshares earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.8198551712188 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Joseph Griffin]

    Northrim BanCorp (NASDAQ: NRIM) and Hometrust Bancshares (NASDAQ:HTBI) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Top 5 Blue Chip Stocks To Invest In Right Now

May 23, 2017: Markets opened higher again Tuesday but have not moved much higher as the session went on. The blue chips performed best with particular strength in financials. Tech stocks and consumer discretionaries are on track for a down finish. WTI crude oil for July delivery settled at $51.47 a barrel, up 0.7%. June gold dipped 0.5% for the day to settle at $1,255.60. Equities were headed for a mixed close shortly before the bell as the DJIA traded up 0.16% for the day, the S&P 500 traded up 0.14%, and the Nasdaq Composite traded down 0.01%.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was The Goldman Sachs Group Inc. (NYSE: GS) which traded up 1.75% at $219.80. The stock’s 52-week range is $138.20 to $3255.15. Volume was about 30% below the daily average of around 3.7 million shares. The company had no specific news Monday.

JPMorgan Chase & Co. (NYSE: JPM) traded up 1.28% at $85.78. The stock’s 52-week range is $57.05 to $93.98. Volume was about 40% below the daily average of around 14.8 million shares. The big bank had no specific news.

Top 5 Blue Chip Stocks To Invest In Right Now: Sensata Technologies Holding N.V.(ST)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Sensata Technologies (ST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    News coverage about Sensata Technologies (NYSE:ST) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of media coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Sensata Technologies earned a news sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the scientific and technical instruments company an impact score of 47.3141406855551 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Ethan Ryder]

    Oppenheimer Asset Management Inc. cut its stake in Sensata Technologies Ltd (NYSE:ST) by 15.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 32,199 shares of the scientific and technical instruments company’s stock after selling 6,012 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Sensata Technologies were worth $1,625,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Sensata Technologies (ST)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Blue Chip Stocks To Invest In Right Now: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Press coverage about Catabasis Pharmaceuticals (NASDAQ:CATB) has been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Catabasis Pharmaceuticals earned a media sentiment score of 0.05 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 44.9364257314523 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Max Byerly]

    These are some of the news articles that may have effected Accern’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

    A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

Top 5 Blue Chip Stocks To Invest In Right Now: Stepan Company(SCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.

    Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Joseph Griffin]

    Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Stephan Byrd]

    Sociall (CURRENCY:SCL) traded down 8.5% against the US dollar during the 24-hour period ending at 0:00 AM E.T. on June 10th. During the last seven days, Sociall has traded 24.1% lower against the US dollar. Sociall has a total market capitalization of $2.31 million and $3,076.00 worth of Sociall was traded on exchanges in the last day. One Sociall token can now be purchased for approximately $0.14 or 0.00002034 BTC on cryptocurrency exchanges including HitBTC, Mercatox, Bancor Network and YoBit.

Top 5 Blue Chip Stocks To Invest In Right Now: KMG Chemicals, Inc.(KMG)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    KMG Chemicals (NYSE:KMG) Q3 2018 Earnings Conference CallJun. 11, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Morgan Dempsey Capital Management LLC lowered its stake in KMG Chemicals, Inc. (NYSE:KMG) by 57.1% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,424 shares of the specialty chemicals company’s stock after selling 20,490 shares during the period. Morgan Dempsey Capital Management LLC owned 0.10% of KMG Chemicals worth $925,000 at the end of the most recent quarter.

Top 5 Blue Chip Stocks To Invest In Right Now: National Grid Transco, PLC(NGG)

Advisors’ Opinion:

  • [By Logan Wallace]

    Reaves W H & Co. Inc. lessened its holdings in National Grid plc (NYSE:NGG) by 15.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 275,481 shares of the utilities provider’s stock after selling 49,687 shares during the period. Reaves W H & Co. Inc.’s holdings in National Grid were worth $15,546,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Tyler Crowe]

    National Grid (NYSE:NGG) has been about as solid of a dividend investment as any investor could ask for over the past decade. The company is the epitome of utility stocks as its regulated electricity and natural gas transmission businesses bear almost no commodity price or power-generation risk. For investors, the trade-off for that stability has been a rather slow rate of growth.

  • [By Stephan Byrd]

    MML Investors Services LLC lessened its holdings in National Grid plc (NYSE:NGG) by 8.7% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 34,440 shares of the utilities provider’s stock after selling 3,290 shares during the quarter. MML Investors Services LLC’s holdings in National Grid were worth $1,943,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    National Grid (NYSE: NGG) and EnLink Midstream Partners (NYSE:ENLK) are both utilities companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, risk, valuation, dividends, earnings and analyst recommendations.

Best Financial Stocks To Own For 2019

Adhil Shetty

Tax planning should be a regular and a continuous process, and not once-in-a-year formality. To avoid last minute hassles, it is best to start saving early by opting for tax efficient saving instruments. However, if you havent been able to accomplish the goals this year, then you dont need to worry as there are some last-minute tax saving ideas to help you sail through.

Go for life insurance term plan

If you have not yet taken adequate life cover for yourself, then you are putting your family at a high risk. A term policy can help your family get financial support after your death. Term policy provides pure insurance cover with no investment benefits. A tax deduction benefit of up to Rs 1.5 lakh is allowed under the Sec 80 (C) of the Income Tax Act. You can buy life insurance term policy through offline mode or directly using the online mode. While buying through the offline mode, you may need to pay higher amount because of agents involvement and it could be time consuming, but if you buy it online, then you could save money as well as the processing time will be fast.

Best Financial Stocks To Own For 2019: Stepan Company(SCL)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Stepan Company (NYSE: SCL) were down 14 percent to $76.53 as the company posted downbeat Q1 results.

    Epizyme, Inc. (NASDAQ: EPZM) was down, falling around 14 percent to $13.125. Epizyme announced Monday after the close that the FDA issued a partial clinical hold on the U.S. enrollment of new patients in tazemetostat clinical trials.

  • [By Joseph Griffin]

    Stepan (NYSE: SCL) and Unilever (NYSE:UN) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings.

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to

Best Financial Stocks To Own For 2019: CPI Aerostructures, Inc.(CVU)

Advisors’ Opinion:

  • [By Lisa Levin]

    CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.

    SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.

Best Financial Stocks To Own For 2019: Xenon Pharmaceuticals Inc.(XENE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Lisa Levin] Gainers
    Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results.
    MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58.
    Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82.
    Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82.
    Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings.
    Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69.
    PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42.
    LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results.
    Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results.
    Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37.
    Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results.
    Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018.
    HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat.
    Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday.
    Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile.
    Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results.
    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva.
    China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter.
    PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Chris Lange]

    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its XEN901 Phase 1 clinical trial and from its XEN1101 Phase 1 clinical trial at the Eilat Conference on New Antiepileptic Drugs and Devices in Madrid, Spain.